DocGo and NYC Test & Trace Corps Launch Flu Testing Across Mobile Testing Fleet
DocGo’s 50+ Mobile Health, Dual-Use, and SHOW Units Now Comprise Largest Program of Its Kind in the Country
Ambulnz, Inc., d/b/a DocGo, a leading provider of mobile health services and integrated medical mobility solutions that has entered into an agreement to merge with Motion Acquisition Corp. (MOTN), has deployed the largest no-cost co-testing program in the country with multiplex testing that now includes rapid antigen tests for flu A and flu B.
Recommended AI News: Reputation Welcomes Andrew Geisse As Vice President Of Sales
DocGo, in partnership with NYC Test & Trace Corps and NYC Health + Hospitals, made the new tests available last week across their Mobile Health fleet as well as in their dual-use and Street Health and Wellness Outreach (SHOW) units. The single-swab assays test for multiple viruses at once and provide patients with results in as little as 15 minutes.
“DocGo’s Mobile Health concept has proven uniquely valuable to facilitate a range of medical services for underserved communities across the City’s five boroughs,” said DocGo’s President Anthony Capone. “As part of our expanding health coverage for NYC, we’re proud to continue increasing the vital services we can offer to the public.”
Patients will register via DocGo’s proprietary HIPAA-compliant HealthPoint portal, healthcare providers will swab the patient, and results will be provided via digital notification after a 15-minute wait.
“I am glad we can offer these tests at the outset of the flu season, so that patients can quickly know their diagnosis and seek the resources they need,” said NYC Test & Trace Corps Executive Director Dr. Ted Long.
[To share your insights with us, please write to firstname.lastname@example.org ]